Public Health or Corporate Wealth?

maida.beth@gmail.com
Author : Maida Taylor
Tue,2012 10 30 15:30

I am sitting in an auditorium at Georgetown University attending a symposium on the influence of the pharmaceutical industry on scientific publications and continuing medical education.  This is a decidedly hostile crowd.  The crusaders are all here, including Arnold Relman, MD, professor of medicine at Harvard Medical School.  He is a former editor of the New England Journal of Medicine (1977–91) and evidences such vigorous idealism I cannot believe he was born in 1923.